Navigation Links
Technology transforms health care
Date:4/22/2013

TAMPA, Fla. (April 22, 2013) The current special issue of Technology and Innovation Proceedings of the National Academy of Inventors (https://www.cognizantcommunication.com/component/content/article/636), devoted to studies on medical technology and health care delivery, focuses on a wide range of topics, from new technologies to reduce the cost of health care to understanding the human microbiome.

"This special issue of Technology and Innovation on transformative health care technologies truly explores new frontiers where technology and health care cross," said Dr. Paul R. Sanberg, senior vice president for Research & Innovation at the University of South Florida and president of the National Academy of Inventors (NAI). "The pioneering researchers who contributed to this issue are leading us into a new era in health that promises to be more efficacious, less expensive and as personal as an individual's health data, microbes and brain cells."

Automated Educational Intervention reduces prescription and hospital costs

A study into the effectiveness of a program to analyze prescription data launched in Missouri in 2003 by Care Management Technologies (CMT), found that physicians who received educational intervention about their patients' prescriptions ultimately helped reduce the costs of care for their Medicaid patients with schizophrenia.

"Pharmacy costs were growing 15 percent annually, and the greatest growth was in psychotropic drugs," says study lead author John P. Docherty of Care Management Technologies, Inc., Weill Cornell Medical College. The study analyzed the CMT program's ability to determine, from prescription data from 2002 to 2005, the deviations from best practices that could increase pharmacy and service costs for a Medicaid subset of patients (173,609) with schizophrenia. According to Docherty and his co-authors, by one year later the intervention program resulted in cost reductions for an estimated 6,310 patients with schizophrenia.

Contact: John P. Docherty, M.D., Care Management Technologies, Inc., 1 Copley Parkway, Suite 500, Morrisville, NC 27560. Email jdochert@med.cornell.edu

Citation: Docherty, J. P.; Veach, J.; Carmel, H.; Oestreich, G. L.; Gorman, J. M.; Parks, J. J. Transforming physician prescribing: the reduction of pharmacy and hospital costs in a population of state Medicaid patients through an automated educational intervention. Technology and Innovation. Appeared or available online: April 18, 2013.

Creating health outcomes indices

There is no widely accepted metric that accurately and timely measures the burden of disease or tracks health status or health system performance through the use of real-world patient data, according to lead author Efthimios Parasidis of Global Health Outcomes, Inc., and co-authors.

"We aim to fill this gap through creating 'health outcomes indices' (HOIs)," explains Parasidis. "By accurately tracking patient outcomes over time, HOIs provide health care stakeholders with a valuable tool with which to measure, assess and predict health outcomes."

According to Parasidis, creating HOIs is dependent on a three-phase framework by which multiple data sources 'real world' patient data, key drivers of patient outcomes, and identification of outcome variables are analyzed to judge the impact of new therapies and justify the allocation of health care dollars.

"Paramount to the long-term fiscal challenges [of health care] is how to manage rising costs without adversely affecting health outcomes," note the authors. "The HOI model seeks to fill this gap by providing stakeholders with a valuable tool to measure, compare and predict health outcomes."

Contact: Efthimios Parasidis, Center for Health Law Studies, St. Louis University School of Law, 3700 Lindell Blvd., St. Louis, MO 63108. Email eparasid@slu.edu

Citation: Parasidis, E.; Petratos, G.; Dastrup, E.; Kamauu, A.; DesRosiers, C.; Zafar, J. A dynamic method for quantifying healthcare status and burden of disease through health outcomes indices. Technology and Innovation. Appeared or available online: April 18, 2013.

The Microbiome and us

Dr. William A. Peck, director of the Center for Health Policy at the Washington University School of Medicine says in "The Microbiome: A Mediator of Human Wellness," that an understanding the human microbiome the tens of trillions of microbes inhabiting our bodies has expanded dramatically through the use of advanced technologies that have increased the mounting evidence of the microbiome's role in human health and disease.

Advanced technologies, particularly culture independent DNA sequencing and computational analytics have been valuable, according to Peck. An innovative research technology called "highly parallel DNA sequencing" allows for simultaneous analysis for standardized data across multiple samples. What additional research may tell us about the function and benefits of the microbiome is critical to future health care, he says.

"Additional research on microbiome manipulations may well yield novel preventive strategies and treatments," Peck concludes.

Contact: William A. Peck, M.D., Director, Center for Health Policy, Washington University in St. Louis, One Brookings Dr., Campus Box 1162, Charles Knight Education Center, Room 166, St. Louis, MO 63130. Email peckw@wustl.edu

Citation: Peck, W. A. The microbiome: a mediator of human wellness. Technology and Innovation. Appeared or available online: April 18, 2013.


'/>"/>

Contact: Judy Lowry
jhlowry@usf.edu
813-974-3181
University of South Florida (USF Innovation)
Source:Eurekalert

Related biology news :

1. Labor der Zukunft -- Tomorrows laboratory technology
2. The future of plant science - a technology perspective
3. The future of plant science a technology perspective
4. Ultracold matter technology from CU and SRI International licensed to Boulders ColdQuanta
5. UF researchers look for ways to make an emerging technology safe for environment
6. Breast cancer risk gene discovery fast tracked by new technology
7. Obese patients face higher radiation exposure from CT scans -- but new technology can help
8. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
9. Powerful sequencing technology decodes DNA folding pattern
10. New technology tracks sparrow migration for first time from California to Alaska
11. M2SYS Technology Partners with Hitachi to Offer Innovative Biometric Finger Vein Scanner to US Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... CO (PRWEB) , ... May 05, 2016 , ... ... diagnostics, is proud to support the National Stroke Association during National Stroke Awareness ... the association’s Facebook and Twitter pages throughout the month. CereScan will donate ...
(Date:5/4/2016)... ... May 04, 2016 , ... Looking for a gift ... premiere hands-on cooking experience. Offering everything from gourmet cooking classes to weekend culinary ... forget. , Guests that visit LaJollaCooks4u share an experience unlike any other. Each ...
(Date:5/4/2016)... ... , ... Proove Biosciences, Inc. , the commercial and research leader in ... . The partnership is designed to advance research in pain genetics in an effort ... With the new agreement, researchers at Proove Biosciences are able to collaborate with Luda ...
(Date:5/4/2016)...  Bayer today announced that a Phase III ... (regorafenib) tablets for the treatment of patients with ... endpoint of a statistically significant improvement in overall ... and safety of regorafenib in patients with HCC ... The safety and tolerability were generally consistent with ...
Breaking Biology Technology: